Amphastar Pharmaceuticals
AMPH
AMPH
138 hedge funds and large institutions have $412M invested in Amphastar Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 49 increasing their positions, 48 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1% less capital invested
Capital invested by funds: $418M → $412M (-$6.27M)
Holders
138
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$15M | |
| 2 | +$6.28M | |
| 3 | +$5.97M | |
| 4 |
Goldman Sachs
New York
|
+$2.28M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$2.01M |
Top Sellers
| 1 | -$13.1M | |
| 2 | -$6.11M | |
| 3 | -$2.58M | |
| 4 |
Fisher Asset Management
Camas,
Washington
|
-$1.81M |
| 5 |
MC
Menta Capital
San Francisco,
California
|
-$1.51M |